Literature DB >> 24296239

Mineral particle size in children with osteogenesis imperfecta type I is not increased independently of specific collagen mutations.

Nadja Fratzl-Zelman1, Ingo Schmidt2, Paul Roschger3, Francis H Glorieux4, Klaus Klaushofer3, Peter Fratzl2, Frank Rauch4, Wolfgang Wagermaier2.   

Abstract

Osteogenesis imperfecta (OI) type I represents the mildest form of OI and is usually caused by two classes of autosomal dominant mutations in collagen type I: haploinsufficiency leading to a reduced quantity of structurally normal collagen (quantitative mutation), or sequence abnormalities generating structurally aberrant collagen chains (qualitative mutation). An abnormally high bone matrix mineralization has been observed in all OI cases investigated so far, independently of mutation type. This raises the question whether the increased amount of mineral is due to mineral particles growing to larger sizes or to a higher number of more densely packed particles. For this reason, we revisit the problem by investigating the mineral particle size in cancellous bone from two subsets of the previously analyzed biopsies (patient's age: 2-4.2 and 7.6-11years) comparing OI quantitative mutations (n=5), OI qualitative mutations (n=5) and controls (n=6). We used a combined small-angle X-ray scattering (SAXS) and wide-angle X-ray diffraction (WAXD) setup with a beam diameter of 10μm of synchrotron radiation, which allows the determination of mineral particle characteristics in 10μm thick sections at the same positions where the matrix mineralization density was previously determined. The thickness parameter of mineral particles (T) was obtained from SAXS data and the mineral volume fraction was calculated from the mean calcium content of the bone matrix determined by quantitative back-scattered electron imaging (qBEI). The combination of these two quantities allowed calculating the true particle width (W) of the plate-like mineral crystals. T was larger in the older than in the younger age-group independently of genotype (p<0.004) and was larger in the controls than in each OI group. The qBEI results showed that the mineral volume fraction increased from 32.45wt.% in controls to 36.44wt.% in both OI groups (corresponding to a 12% increase in relative terms). Combining these data, we find that also W was larger in the older than in the younger age-group (p<0.002), but stayed equal or smaller in both OI genotypes (controls: 2.3nm±0.04, OI qualitative: 2.2±0.05; OI quantitative 2.3±0.04, mean±SEM). A linear regression analysis even suggests a slower increase of W in qualitative OI as compared to quantitative OI and controls, where the particle sizes stayed similar at all ages. We thus conclude that the high mineral density in human OI is not due to increased particle size but rather to increased particle packing density. The lack of an observed difference between the two classes of mutations suggests the occurrence of a bone cell defect downstream of the collagen mutation.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bone biopsies; Haploinsufficiency and structural mutations; Mineral particle size; Osteogenesis imperfecta; Quantitative backscattered electron microscopy; Synchrotron small angle X-ray scattering

Mesh:

Substances:

Year:  2013        PMID: 24296239     DOI: 10.1016/j.bone.2013.11.023

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  27 in total

Review 1.  Bone biology: insights from osteogenesis imperfecta and related rare fragility syndromes.

Authors:  Roberta Besio; Chi-Wing Chow; Francesca Tonelli; Joan C Marini; Antonella Forlino
Journal:  FEBS J       Date:  2019-07-05       Impact factor: 5.542

2.  Finite element analysis of bone strength in osteogenesis imperfecta.

Authors:  Peter Varga; Bettina M Willie; Chris Stephan; Kenneth M Kozloff; Philippe K Zysset
Journal:  Bone       Date:  2020-01-22       Impact factor: 4.398

3.  Hindlimb Skeletal Muscle Function and Skeletal Quality and Strength in +/G610C Mice With and Without Weight-Bearing Exercise.

Authors:  Youngjae Jeong; Stephanie M Carleton; Bettina A Gentry; Xiaomei Yao; J Andries Ferreira; Daniel J Salamango; MaryAnn Weis; Arin K Oestreich; Ashlee M Williams; Marcus G McCray; David R Eyre; Marybeth Brown; Yong Wang; Charlotte L Phillips
Journal:  J Bone Miner Res       Date:  2015-05-14       Impact factor: 6.741

4.  Mutations That Alter the Carboxy-Terminal-Propeptide Cleavage Site of the Chains of Type I Procollagen Are Associated With a Unique Osteogenesis Imperfecta Phenotype.

Authors:  Tim Cundy; Michael Dray; John Delahunt; Jannie Dahl Hald; Bente Langdahl; Chumei Li; Marta Szybowska; Shehla Mohammed; Emma L Duncan; Aideen M McInerney-Leo; Patricia G Wheeler; Paul Roschger; Klaus Klaushofer; Jyoti Rai; MaryAnn Weis; David Eyre; Ulrike Schwarze; Peter H Byers
Journal:  J Bone Miner Res       Date:  2018-04-18       Impact factor: 6.741

Review 5.  Bone quality changes associated with aging and disease: a review.

Authors:  Adele L Boskey; Laurianne Imbert
Journal:  Ann N Y Acad Sci       Date:  2017-12       Impact factor: 5.691

6.  Hypermineralization and High Osteocyte Lacunar Density in Osteogenesis Imperfecta Type V Bone Indicate Exuberant Primary Bone Formation.

Authors:  Stéphane Blouin; Nadja Fratzl-Zelman; Francis H Glorieux; Paul Roschger; Klaus Klaushofer; Joan C Marini; Frank Rauch
Journal:  J Bone Miner Res       Date:  2017-06-26       Impact factor: 6.741

7.  Non-Lethal Type VIII Osteogenesis Imperfecta Has Elevated Bone Matrix Mineralization.

Authors:  Nadja Fratzl-Zelman; Aileen M Barnes; MaryAnn Weis; Erin Carter; Theresa E Hefferan; Giorgio Perino; Weizhong Chang; Peter A Smith; Paul Roschger; Klaus Klaushofer; Francis H Glorieux; David R Eyre; Cathleen Raggio; Frank Rauch; Joan C Marini
Journal:  J Clin Endocrinol Metab       Date:  2016-07-06       Impact factor: 5.958

Review 8.  Osteogenesis imperfecta and therapeutics.

Authors:  Roy Morello
Journal:  Matrix Biol       Date:  2018-03-11       Impact factor: 11.583

Review 9.  Changes in the degree of mineralization with osteoporosis and its treatment.

Authors:  Paul Roschger; Barbara Misof; Eleftherios Paschalis; Peter Fratzl; Klaus Klaushofer
Journal:  Curr Osteoporos Rep       Date:  2014-09       Impact factor: 5.096

Review 10.  The Role of Matrix Composition in the Mechanical Behavior of Bone.

Authors:  Mustafa Unal; Amy Creecy; Jeffry S Nyman
Journal:  Curr Osteoporos Rep       Date:  2018-06       Impact factor: 5.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.